These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 19645781)

  • 1. Significance of periductal lymphatic and blood vascular densities in intraductal carcinoma of the breast.
    El-Gohary YM; Metwally G; Saad RS; Robinson MJ; Mesko T; Poppiti RJ
    Breast J; 2009; 15(3):261-7. PubMed ID: 19645781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of intratumoral and peritumoral lymphatic density and blood vessel density in invasive breast carcinomas.
    El-Gohary YM; Metwally G; Saad RS; Robinson MJ; Mesko T; Poppiti RJ
    Am J Clin Pathol; 2008 Apr; 129(4):578-86. PubMed ID: 18343785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphatic vessel density as prognostic marker in esophageal adenocarcinoma.
    Saad RS; Lindner JL; Liu Y; Silverman JF
    Am J Clin Pathol; 2009 Jan; 131(1):92-8. PubMed ID: 19095571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic vessel density as a prognostic marker in clinical stage I endocervical adenocarcinoma.
    Saad RS; Ismiil N; Ghorab Z; Nofech-Mozes S; Dubé V; Covens A; Khalifa MA
    Int J Gynecol Pathol; 2010 Jul; 29(4):386-93. PubMed ID: 20567154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvessel and lymphatic density in tubular carcinoma of the breast: comparative study with invasive low-grade ductal carcinoma.
    Fernandez-Aguilar S; Jondet M; Simonart T; Nöel JC
    Breast; 2006 Dec; 15(6):782-5. PubMed ID: 16931017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accurate assessment of lymph vessel tumor emboli in invasive ductal carcinoma of the breast according to tumor areas, and their prognostic significance.
    Yamauchi C; Hasebe T; Iwasaki M; Imoto S; Wada N; Fukayama M; Ochiai A
    Hum Pathol; 2007 Feb; 38(2):247-59. PubMed ID: 17056095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An immunohistochemical analysis of angiogenesis in invasive breast cancer with correlations to clinicopathologic predictors.
    Nakopoulou L; Lekkas N; Lazaris AC; Athanassiadou P; Giannopoulou I; Mavrommatis J; Davaris P
    Anticancer Res; 1999; 19(5C):4547-53. PubMed ID: 10650809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of lymphovascular invasion diagnosed by lymphatic endothelium immunostaining in breast cancer patients.
    Tezuka K; Onoda N; Takashima T; Takagaki K; Ishikawa T; Wakasa T; Wakasa K; Hirakawa K
    Oncol Rep; 2007 May; 17(5):997-1003. PubMed ID: 17390035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of cyclooxygenase-2 and aromatase immunohistochemical expression in invasive ductal carcinoma, ductal carcinoma in situ, and adjacent normal epithelium.
    Oliveira VM; Piato S; Silva MA
    Breast Cancer Res Treat; 2006 Feb; 95(3):235-41. PubMed ID: 16322898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast.
    Sapino A; Bongiovanni M; Cassoni P; Righi L; Arisio R; Deaglio S; Malavasi F
    J Pathol; 2001 Jun; 194(2):254-61. PubMed ID: 11400156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences.
    Mohammed RA; Martin SG; Gill MS; Green AR; Paish EC; Ellis IO
    Am J Surg Pathol; 2007 Dec; 31(12):1825-33. PubMed ID: 18043036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expressions of D2-40 and CD34 in invasive ductal carcinoma of the breast and the clinical implications].
    Zhen LF; Ye CS; Liu MF; Ding GP; Liao JJ
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jul; 30(7):1548-51. PubMed ID: 20650763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunophenotype of intraductal carcinoma.
    Bose S; Lesser ML; Norton L; Rosen PP
    Arch Pathol Lab Med; 1996 Jan; 120(1):81-5. PubMed ID: 8554451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased expression of CD146 and microvessel density (MVD) in invasive micropapillary carcinoma of the breast: Comparative study with invasive ductal carcinoma-not otherwise specified.
    Li W; Yang D; Wang S; Guo X; Lang R; Fan Y; Gu F; Zhang X; Niu Y; Yan X; Fu L
    Pathol Res Pract; 2011 Dec; 207(12):739-46. PubMed ID: 22051146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does thymidine phosphorylase correlate with angiogenesis in intraductal carcinoma of the breast?
    Erkus M; Meteoglu I; Culhaci N; Meydan N; Erdogdu I
    Saudi Med J; 2006 Sep; 27(9):1329-33. PubMed ID: 16951768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follicular thyroid carcinoma invades venous rather than lymphatic vessels.
    Lin X; Zhu B; Liu Y; Silverman JF
    Diagn Pathol; 2010 Jan; 5():8. PubMed ID: 20205756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis as determined by computerised image analysis and the risk of early relapse in women with invasive ductal breast carcinoma.
    Olewniczak S; Chosia M; Kołodziej B; Kwas A; Kram A; Domagała W
    Pol J Pathol; 2003; 54(1):53-9. PubMed ID: 12817881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
    Rabban JT; Chen YY
    Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic microvessel density as prognostic marker in colorectal cancer.
    Saad RS; Kordunsky L; Liu YL; Denning KL; Kandil HA; Silverman JF
    Mod Pathol; 2006 Oct; 19(10):1317-23. PubMed ID: 16799477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of oncogenic markers in ductal carcinoma in situ of the breast: a clinicopathologic study.
    Altintas S; Lambein K; Huizing MT; Braems G; Asjoe FT; Hellemans H; Van Marck E; Weyler J; Praet M; Van den Broecke R; Vermorken JB; Tjalma WA
    Breast J; 2009; 15(2):120-32. PubMed ID: 19292797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.